The following pages link to (Q4428801):
Displaying 25 items.
- Adaptive isotonic estimation of the minimum effective and peak doses in the presence of covariates (Q419309) (← links)
- Adaptive Bayesian compound designs for dose finding studies (Q434557) (← links)
- Simulation-based sequential Bayesian design (Q997303) (← links)
- A review of phase 2-3 clinical trial designs (Q1029784) (← links)
- Bayesian learning of dose-response parameters from a cohort under response-guided dosing (Q1681360) (← links)
- Incorporating Bayesian ideas into health-care evaluation (Q1766322) (← links)
- Bayesian statistics and the efficiency and ethics of clinical trials (Q1766323) (← links)
- Is the FDA too conservative or too aggressive?: a Bayesian decision analysis of clinical trial design (Q2000854) (← links)
- Approximating the operating characteristics of Bayesian uncertainty directed trial designs (Q2156810) (← links)
- Flexible link continual reassessment methods for trivariate binary outcome phase I/II trials (Q2320854) (← links)
- Optimal stopping for response-guided dosing (Q2328340) (← links)
- Population modelling of patient responses in antidepressant studies: a stochastic approach (Q2341866) (← links)
- Celebrating 70: an interview with Don Berry (Q2634661) (← links)
- Bayesian design for clinical trials with a constraint on the total available dose (Q2736795) (← links)
- Optimizing the concentration and bolus of a drug delivered by continuous infusion (Q2893431) (← links)
- (Q3002376) (← links)
- Dose-Finding Designs for HIV Studies (Q3078854) (← links)
- Seamlessly Expanding a Randomized Phase II Trial to Phase III (Q3079028) (← links)
- Easy-to-implement Bayesian methods for dose-escalation studies in healthy volunteers (Q4419374) (← links)
- Phase I (or Phase II) Dose-Ranging Clinical Trials: Proposal of a Two-Stage Bayesian Design (Q4796210) (← links)
- Min-Max Optimal Design of Two-Armed Trials with Side Information (Q5084640) (← links)
- Dynamic Programming for Response-Adaptive Dose-Finding Clinical Trials (Q5086016) (← links)
- A combined proof of concept and dose finding study with multiple endpoints: A Bayesian adaptive design in chronic prostatitis/chronic pelvic pain syndrome (Q5208130) (← links)
- Implementation of a Bayesian Design in a Dose‐Escalation Study of an Experimental Agent in Healthy Volunteers (Q5450494) (← links)
- Adaptive Bayesian phase I clinical trial designs for estimating the maximum tolerated doses for two drugs while fully utilizing all toxicity information (Q6085905) (← links)
